Sunday, September 25th, 2022 09:15:33

Covid-19: Free booster dose for people aged between 18 and 59 years at govt centres begins

Updated: July 15, 2022 11:15 am

The 75-day COVID Vaccination Amrit Mahotsava will commence from today to provide free precaution doses to all eligible populations at Government COVID Vaccination Centres. The special drive is aimed to increase uptake of the Precaution Dose of COVID Vaccine among the eligible adult population 18 years and above. Union Health Ministry said, this special COVID vaccination drive is a part of the celebration for ‘Azadi Ka Amrit Mahotsav’.

Union Health Secretary Rajesh Bhushan held a virtual meeting with Health Secretaries of State and Union Territories yesterday. He urged all States and UTs to give an intensive and ambitious push toward full COVID vaccination coverage by vaccinating all eligible beneficiaries and covering them with precautionary doses. Mr Bhushan highlighted that less percentage of precaution doses uptake among population groups aged 18 years and above is eight percent and persons aged 60 years and above is only 27 percent is a cause of concern. He said, all persons 18 years and above who have completed six months (or 26 weeks) from the date of administration of 2nd dose are eligible for the Precaution Dose.

States and UTs were urged to implement COVID Vaccination Amrit Mahotsava for 75 days as ‘Jan Abhiyaan’ with massive mass mobilization, through a camp approach. They were advised to organize special vaccination camps on the routes of Char Dham Yatra in Uttarakhand, Amarnath Yatra in Jammu and Kashmir, and Kanwar Yatra in all States and UTs of North-India as well as major Melas and congregations. Mr Bhushan also advised to operationalize Special Workplace Vaccination Camps at big office complexes, industrial establishments, Railway Stations, Inter-State Bus Stations, in schools and colleges. He said, during the Special Vaccination Camps, the vaccination has to be done mandatorily through CoWIN, and vaccination certificate is to be provided.

Comments are closed here.